Diffuse Large B-Cell Lymphoma With Primary Treatment Failure: Ultra-High Risk Features and Benchmarking for Experimental Therapies
American Journal of Hematology - United States
doi 10.1002/ajh.24615
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 17, 2017
Authors
Publisher
Wiley